| 000 | 01751 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513031115.0 | ||
| 264 | 0 | _c19941013 | |
| 008 | 199410s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/0959-8049(94)90529-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDel Mastro, L | |
| 245 | 0 | 0 |
_aA pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c1994 |
||
| 300 |
_a606-10 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aHematologic Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 700 | 1 | _aGarrone, O | |
| 700 | 1 | _aSertoli, M R | |
| 700 | 1 | _aCanavese, G | |
| 700 | 1 | _aCatturich, A | |
| 700 | 1 | _aGuenzi, M | |
| 700 | 1 | _aRosso, R | |
| 700 | 1 | _aVenturini, M | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 30A _gno. 5 _gp. 606-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0959-8049(94)90529-0 _zAvailable from publisher's website |
| 999 |
_c7521119 _d7521119 |
||